Nishimura S - Search Results

1

Can ABCF2 protein expression predict the prognosis of uterine cancer?

Nishimura S, Tsuda H, Miyagi Y, Hirasawa A, Suzuki A, Kataoka F, Nomura H, Chiyoda T, Banno K, Fujii T, Susumu N, Aoki D. Nishimura S, et al. Br J Cancer. 2008 Nov 18;99(10):1651-5. doi: 10.1038/sj.bjc.6604734. Br J Cancer. 2008. PMID: 19002184 Free PMC article.

2

Expression of hypoxia-inducible 2 (HIG2) protein in uterine cancer.

Nishimura S, Tsuda H, Nomura H, Kataoka F, Chiyoda T, Tanaka H, Tanaka K, Susumu N, Aoki D. Nishimura S, et al. Eur J Gynaecol Oncol. 2011;32(2):146-9. Eur J Gynaecol Oncol. 2011. PMID: 21614900

3

Phase I-II study of irinotecan (CPT-11) plus nedaplatin (254-S) with recombinant human granulocyte colony-stimulating factor support in patients with advanced or recurrent cervical cancer.

Tsuda H, Hashiguchi Y, Nishimura S, Miyama M, Nakata S, Kawamura N, Negoro S. Tsuda H, et al. Among authors: nishimura s. Br J Cancer. 2004 Sep 13;91(6):1032-7. doi: 10.1038/sj.bjc.6602076. Br J Cancer. 2004. PMID: 15292935 Free PMC article. Clinical Trial.

4

Phase II study of irinotecan plus doxorubicin for early recurrent or platinum-refractory ovarian cancer: interim analysis.

Nishimura S, Tsuda H, Hashiguchi Y, Kokawa K, Nishimura R, Ishiko O, Kamiura S, Hasegawa K, Umesaki N. Nishimura S, et al. Among authors: nishimura r. Int J Gynecol Cancer. 2007 Jan-Feb;17(1):159-63. doi: 10.1111/j.1525-1438.2006.00728.x. Int J Gynecol Cancer. 2007. PMID: 17291248 Clinical Trial.

5

The effect of an old surgical scar on sentinel node mapping in patients with breast cancer: a report of five cases.

Tada K, Nishimura S, Miyagi Y, Takahashi K, Makita M, Iwase T, Yoshimoto M, Kasumi F, Koizumi M. Tada K, et al. Among authors: nishimura s. Eur J Surg Oncol. 2005 Oct;31(8):840-4. doi: 10.1016/j.ejso.2005.05.005. Eur J Surg Oncol. 2005. PMID: 16009528

6

The feasibility of sentinel node biopsy in the previously treated breast.

Koizumi M, Koyama M, Tada K, Nishimura S, Miyagi Y, Makita M, Yoshimoto M, Iwase T, Horii R, Akiyama F, Saga T. Koizumi M, et al. Among authors: nishimura s. Eur J Surg Oncol. 2008 Apr;34(4):365-8. doi: 10.1016/j.ejso.2007.04.007. Epub 2007 May 25. Eur J Surg Oncol. 2008. PMID: 17532172

7

18F-fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma.

Nakata B, Chung YS, Nishimura S, Nishihara T, Sakurai Y, Sawada T, Okamura T, Kawabe J, Ochi H, Sowa M. Nakata B, et al. Among authors: nishimura s. Cancer. 1997 Feb 15;79(4):695-9. Cancer. 1997. PMID: 9024707

8

Establishment of two new scirrhous gastric cancer cell lines: analysis of factors associated with disseminated metastasis.

Yashiro M, Chung YS, Nishimura S, Inoue T, Sowa M. Yashiro M, et al. Among authors: nishimura s. Br J Cancer. 1995 Nov;72(5):1200-10. doi: 10.1038/bjc.1995.486. Br J Cancer. 1995. PMID: 7577468 Free PMC article.

9

Role of alpha 2 beta 1- and alpha 3 beta 1-integrin in the peritoneal implantation of scirrhous gastric carcinoma.

Nishimura S, Chung YS, Yashiro M, Inoue T, Sowa M. Nishimura S, et al. Br J Cancer. 1996 Nov;74(9):1406-12. doi: 10.1038/bjc.1996.556. Br J Cancer. 1996. PMID: 8912536 Free PMC article.

10

Identification of breast cancer resistant protein/mitoxantrone resistance/placenta-specific, ATP-binding cassette transporter as a transporter of NB-506 and J-107088, topoisomerase I inhibitors with an indolocarbazole structure.

Komatani H, Kotani H, Hara Y, Nakagawa R, Matsumoto M, Arakawa H, Nishimura S. Komatani H, et al. Among authors: nishimura s. Cancer Res. 2001 Apr 1;61(7):2827-32. Cancer Res. 2001. PMID: 11306452

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,097 results

Search Page

Filters